All levelsNo New Dates

Psilocybin Therapy and the Rise of Existential Medicine

This course examines psilocybin therapy and its role in the emerging field of existential medicine. It covers how psilocybin-assisted psychotherapy is studied, prepared for, and conducted in controlled clinical settings.

Provider

Details

30 days

Enrollment

Price on request
This course is currently marked as no new dates.

Course Overview

Psilocybin therapy is presented here as an evolving area of mental health research, with attention to both its therapeutic promise and its limitations. The course explains what psilocybin is, how it is being investigated for conditions such as substance use disorder and treatment-resistant depression, and why it is drawing renewed scientific interest. It also outlines the structure of clinical psilocybin studies, including screening, preparatory sessions, intention-setting, dosing in supervised environments, and placebo-controlled study design. The content is framed for readers interested in psychedelic research, psychotherapy, and the practical realities of clinical use. The course is a fit for learners seeking a clear overview of psilocybin-assisted therapy rather than step-by-step personal guidance. It is based on an interview with Dr. Charles Grob, a psychedelic researcher and professor of psychiatry and pediatrics at UCLA School of Medicine.

Who is this for?

People interested in psychedelic research, mental health treatment models, and the clinical study of psilocybin therapy.

About the Provider

Psychedelic media publication covering education, culture, policy, and practical guidance around psychedelic use and integration.

View Double Blind profile

Course Details

  • PricePrice on request
  • Lifecycle statusNo New Dates
  • Skills
    IntegrationFacilitationPsychotherapyKetamine-Assisted TherapyPsilocybin TherapyEthicsMusic and Set/SettingUnderstanding psilocybin-assisted psychotherapyRecognizing clinical trial structureReviewing screening and preparation processesInterpreting placebo-controlled research designAssessing potential therapeutic uses of psilocybin